These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma. Maloney D Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S35-S36. PubMed ID: 18724296 [TBL] [Abstract][Full Text] [Related]
25. Nonmyeloablative transplantation for solid tumors: a new frontier for allogeneic immunotherapy. Espinoza-Delgado I; Childs RW Expert Rev Anticancer Ther; 2004 Oct; 4(5):865-75. PubMed ID: 15485320 [TBL] [Abstract][Full Text] [Related]
26. Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives. Ringdén O; Le Blanc K APMIS; 2005; 113(11-12):813-30. PubMed ID: 16480452 [TBL] [Abstract][Full Text] [Related]
36. Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning. Veelken H; Wäsch R; Behringer D; Bertz H; Finke J Bone Marrow Transplant; 2000 Oct; 26(8):911-5. PubMed ID: 11081395 [TBL] [Abstract][Full Text] [Related]
37. Current concepts in allogeneic hematopoietic stem cell transplantation. Tabbara IA; Kairouz S; Nahleh Z; Mihalcea AM Anticancer Res; 2003; 23(6D):5055-67. PubMed ID: 14981967 [TBL] [Abstract][Full Text] [Related]
38. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia. Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296 [TBL] [Abstract][Full Text] [Related]